VERAXA Biotech GmbH
 | |
| Branche: | Biotechnology |
| Produkte/Dienstleistungen: | ADC Development and Antibody Screening |
| Standort(e): | 69124 Heidelberg, Carl-Friedrich-Gauß-Ring 5 |
| Gründungsdatum: | 2021 |
| Mitarbeiterzahl: | 32 |
| Das Unternehmen: | VERAXA is an early-stage biotechnology company with game changing functional antibody discovery and conjugation technology yielding ADCs at scale for the treatment of Cancer. Its proprietary high throughput droplet-based microfluidic platform can screen entire immune repertoires with millions of antibody secreting cells for antibody binding, functionality, and internalization on a single-cell level. VERAXA’s unique conjugation technology utilizes fastest bioorthogonal click chemistry coupled with genetic code expansion to precisely and efficiently conjugate payloads/oligos/ radionuclide at freely selectable antibody sites. |
| Gesuchte Fachrichtungen: | Biosciences, Chemistry, Mathematics, Biochemistry, Physics, Computer Sciences, Biotechnology |
| Gesuchte Abschlüsse: | PostDoc, PhD, master, bachelor, technicians |
| Einstiegsmöglichkeiten: | direct entry |
| Traineeprogramme (Zahl der Plätze /Jahr): | No |
| Kontakt: | veraxa.com/jobs/ jobs@veraxa.com |
